ArticleThe Journal of rheumatology2020

Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials.

Stephen J Balevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.